Cytodyn Inc (CYDY)

$0.27 +0.01 (2.46%)
Market Cap 342.26M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,729,200
Avg Vol 1,656,790
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 39%
Beta 1.17
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
my69z
my69z Apr. 5 at 8:39 PM
$CYDY Mrs. Petersons mTNBC LL / Tecentriq news. Reminds of Feb. 2025 mTNBC, for very possibly, addtl toxicities reduced via LL.... "....the Company has initiated two pre-clinical studies in mTNBC that will evaluate possible treatment synergies between leronlimab, an antibody-drug complex treatment (sacituzumab govitecan), and an immune checkpoint inhibitor (pembrolizumab)." Wow @ not only creating market expansions, but also on the path of answering what surely lingered in back of everyone's head ---- shouldn't LL reduce other drugs toxicities too ?? That comment is on verge of proving how deeply valuable of an addtl combo affect, LL brings to the table.... Strengthening Cytodyn leverage of: "any ICI" Wow... ...
0 · Reply
my69z
my69z Apr. 5 at 7:55 PM
$CYDY LL replicate Tecentriq affect for Keytruda too ??.. https://investorshangout.com/post/view?id=6822999 ....
0 · Reply
MGK2
MGK2 Apr. 5 at 7:44 PM
$CYDY Based on the description alone, do you think this is a Cold Tumor or a Hot one?
3 · Reply
my69z
my69z Apr. 5 at 7:22 PM
$CYDY Re: Keytruda & other Ports... https://investorshangout.com/post/view?id=6822997 ...
1 · Reply
Jiha
Jiha Apr. 5 at 7:17 PM
$CYDY classy Easter message
1 · Reply
Jesse21SD
Jesse21SD Apr. 5 at 7:00 PM
$CYDY we basically are going from saying our App should work for the iPhone on Verizon… to our App should work on any phone on any network, and here’s why. LFG!
2 · Reply
GhostofCytomight
GhostofCytomight Apr. 5 at 5:31 PM
$CYDY 🍀 Yeah, “C-Y-D-Y” is CytoDyn—their drug’s Leronlimab, a monoclonal antibody that blocks CCR5 on immune cells. Think of it like jamming a signal that ramps up inflammation or lets tumors hide. It’s called an immune modulator ‘cause it dials down overactive responses—like in COVID storms or cancer evasion—
0 · Reply
bellaboos
bellaboos Apr. 5 at 3:12 PM
$CYDY
1 · Reply
GhostofCytomight
GhostofCytomight Apr. 5 at 2:17 PM
$CYDY GOOD GOD‼️HAPPY EASTER 🐣
1 · Reply
TillThen
TillThen Apr. 5 at 1:00 PM
$CYDY Happy Easter to all who celebrate the Risen Christ!
3 · Reply
Latest News on CYDY
No data available.
my69z
my69z Apr. 5 at 8:39 PM
$CYDY Mrs. Petersons mTNBC LL / Tecentriq news. Reminds of Feb. 2025 mTNBC, for very possibly, addtl toxicities reduced via LL.... "....the Company has initiated two pre-clinical studies in mTNBC that will evaluate possible treatment synergies between leronlimab, an antibody-drug complex treatment (sacituzumab govitecan), and an immune checkpoint inhibitor (pembrolizumab)." Wow @ not only creating market expansions, but also on the path of answering what surely lingered in back of everyone's head ---- shouldn't LL reduce other drugs toxicities too ?? That comment is on verge of proving how deeply valuable of an addtl combo affect, LL brings to the table.... Strengthening Cytodyn leverage of: "any ICI" Wow... ...
0 · Reply
my69z
my69z Apr. 5 at 7:55 PM
$CYDY LL replicate Tecentriq affect for Keytruda too ??.. https://investorshangout.com/post/view?id=6822999 ....
0 · Reply
MGK2
MGK2 Apr. 5 at 7:44 PM
$CYDY Based on the description alone, do you think this is a Cold Tumor or a Hot one?
3 · Reply
my69z
my69z Apr. 5 at 7:22 PM
$CYDY Re: Keytruda & other Ports... https://investorshangout.com/post/view?id=6822997 ...
1 · Reply
Jiha
Jiha Apr. 5 at 7:17 PM
$CYDY classy Easter message
1 · Reply
Jesse21SD
Jesse21SD Apr. 5 at 7:00 PM
$CYDY we basically are going from saying our App should work for the iPhone on Verizon… to our App should work on any phone on any network, and here’s why. LFG!
2 · Reply
GhostofCytomight
GhostofCytomight Apr. 5 at 5:31 PM
$CYDY 🍀 Yeah, “C-Y-D-Y” is CytoDyn—their drug’s Leronlimab, a monoclonal antibody that blocks CCR5 on immune cells. Think of it like jamming a signal that ramps up inflammation or lets tumors hide. It’s called an immune modulator ‘cause it dials down overactive responses—like in COVID storms or cancer evasion—
0 · Reply
bellaboos
bellaboos Apr. 5 at 3:12 PM
$CYDY
1 · Reply
GhostofCytomight
GhostofCytomight Apr. 5 at 2:17 PM
$CYDY GOOD GOD‼️HAPPY EASTER 🐣
1 · Reply
TillThen
TillThen Apr. 5 at 1:00 PM
$CYDY Happy Easter to all who celebrate the Risen Christ!
3 · Reply
Maggie16
Maggie16 Apr. 5 at 9:35 AM
$CYDY Wishing all that celebrate a Very Happy Easter . 🐇🐣
1 · Reply
geetee12345
geetee12345 Apr. 5 at 9:24 AM
$CYDY Happy Easter to all that celebrate!
0 · Reply
LadyDuckSnot
LadyDuckSnot Apr. 5 at 6:57 AM
$CYDY Wow. Some loser who doesn't own the stock yet spends years bashing it, makes their own predictions that are always wrong, tries to call out other people? Baaahaahhaaaahaaa!! Pathetic.
1 · Reply
Djjazzyjeff
Djjazzyjeff Apr. 5 at 6:03 AM
$CYDY I mean there are so many MGK posts out there that are flat out wrong it's hard to pick one to tear apart. I'm sure if I went even further back it would be worse. Who here has been sitting here since 2024? Loollllllll did you believe MGK2? Baaaaaaaaaahahahhahahaha
1 · Reply
Djjazzyjeff
Djjazzyjeff Apr. 5 at 6:01 AM
$CYDY let's look at a post from 2 yrs ago by MGK: "The Virtuous Vs. The Vitiated" “The timeline is… submit by end of January 2024… FDA… end of February 2024… it shall happen, because it is Unstoppable.” Reality: No clean, rapid approval No smooth progression Still stuck in slow, messy trial evolution years later The trial shall be run to a successful completion.” “The preliminary results are going to be stellar.” “p value… less than 0.001… unequivocally and decisively show that CytoDyn is winning. Reality: You got tiny, preliminary, ambiguous data 3/5 type signals being hyped No “unequivocal” anything No strong clinical endpoints Big Pharma… might want to own a piece of this or gobble it up entirely.” “At this point, CytoDyn is bid upon and bid up rapidly. Reality: No buyout No serious partnership Stock sitting around $0.20–$0.30 This unequivocal data set… is inevitable.” “CytoDyn has already won the Safety part… Putting the two together means CytoDyn is winning Reality: No pivotal data No approval
0 · Reply
HouseintheCountry
HouseintheCountry Apr. 5 at 5:46 AM
$CYDY appears that the confidence level is up. Waiting for the sp to reflect the new paradigm.
1 · Reply
Djjazzyjeff
Djjazzyjeff Apr. 5 at 4:44 AM
$CYDY have the pumpers ever been right? Ever?
1 · Reply
my69z
my69z Apr. 5 at 2:30 AM
$CYDY I'll be 1st to say it --- i don't give a daym if Mgt decided better to remain a seperate entity & develop into a fully integrated corporation --- via 3rd party outsourcing. Share structure going to 20-30b shares. ( napkin estimate, etc.. @ a few billion cost ) Personally would not see that as any concern what soever. The operating profit margin potentials is so massive, it could be bought back with ease. If chosen to. Due to not even close to being cost prohibitive, a stretch / hard stop internal scenario being --- willing to go all the way "on our own". Just recently alone: Dated Options, 8/8 patients, 4/4 patients, Dr. J patent filing Assignee Cytodyn, 8/9 different sponsor funded expanded trials for PD-L1, Restores T-cell, Chemo/Radio Synergies, Stemness, $17M funding to 2027, Jake2212 posted thought when Production Readiness in press release....now Dosing & Duration on our own. Never a better potential for building durable, lasting dominance in any...industry ....
1 · Reply
Livingeasy
Livingeasy Apr. 5 at 2:22 AM
$CYDY Happy Easter Longs, may we be 🍀🍀🍀 ! Think I saw a Bunny Rabbit 🐇!
0 · Reply
my69z
my69z Apr. 5 at 12:32 AM
$CYDY Supply availability optics: *Direct indications. *At-risk populations. *Repurposed combo trials. We focus on which company should partner/buy Leronlimab. There's an even more lucrative angle being overlooked --- the number of companies who need a guarantee of supply, is unlimited. Cytodyn has 12 yrs of manufacturing rights @ 1st full FDA approval. If you do not have a direct equity partnership with Cytodyn, you better pre-pay to secure supply. So when only 1 or 2 companies are mentioned as hopeful partners --- think about how many that excludes..... Companies within many types of industries will need Sequence LL, for their own combinations. Be it clinical & market approvals. 12 yrs --- & Generics are not a mfgr'ing concern either. AKA: Profits on the scale of manufacturing volume, absolutely dwarfs a one-time buy-out offer to Cytodyn shareholders. Cytodyn shareholders, can not afford to sell Leronlimab ...
1 · Reply
PhyscoChicken
PhyscoChicken Apr. 4 at 11:39 PM
$CYDY The 7000 year journey of CCR5 to the bedside. Presentation April 28th, by Richard Pestell https://mta.hu/aebudapest-events/2026-04-28-richard-g-pestell-cancer-vulnerabilities-the-surprising-7000-year-journey-of-ccr5-to-the-bedside-6180
5 · Reply
HEDZUP
HEDZUP Apr. 4 at 11:19 PM
$CYDY
0 · Reply